Fischer, J.;                     Erkner, E.;                     Radszuweit, P.;                     Hentrich, T.;                     Keppeler, H.;                     Korkmaz, F.;                     Schulze-Hentrich, J.;                     Fitzel, R.;                     Lengerke, C.;                     Schneidawind, D.;     
    et al.    Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib. Int. J. Mol. Sci. 2024, 25, 12760.
    https://doi.org/10.3390/ijms252312760
    AMA Style
    
                                Fischer J,                                 Erkner E,                                 Radszuweit P,                                 Hentrich T,                                 Keppeler H,                                 Korkmaz F,                                 Schulze-Hentrich J,                                 Fitzel R,                                 Lengerke C,                                 Schneidawind D,         
        et al.        Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib. International Journal of Molecular Sciences. 2024; 25(23):12760.
        https://doi.org/10.3390/ijms252312760
    
    Chicago/Turabian Style
    
                                Fischer, Jacqueline,                                 Estelle Erkner,                                 Pia Radszuweit,                                 Thomas Hentrich,                                 Hildegard Keppeler,                                 Fulya Korkmaz,                                 Julia Schulze-Hentrich,                                 Rahel Fitzel,                                 Claudia Lengerke,                                 Dominik Schneidawind,         
         and et al.        2024. "Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib" International Journal of Molecular Sciences 25, no. 23: 12760.
        https://doi.org/10.3390/ijms252312760
    
    APA Style
    
                                Fischer, J.,                                 Erkner, E.,                                 Radszuweit, P.,                                 Hentrich, T.,                                 Keppeler, H.,                                 Korkmaz, F.,                                 Schulze-Hentrich, J.,                                 Fitzel, R.,                                 Lengerke, C.,                                 Schneidawind, D.,                                 & Schneidawind, C.        
        
        (2024). Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib. International Journal of Molecular Sciences, 25(23), 12760.
        https://doi.org/10.3390/ijms252312760